News & Press Releases
For all media inquiries, please contact us.
2Morrow Recognized Among Top Digital Therapeutics Companies of 2025
2Morrow has been named one of the 20 Innovative Digital Therapeutics Companies of 2025 by PharmaShots. This recognition highlights organizations advancing the field of digital health through clinically grounded, technology-enabled solutions. We are honored to be included alongside others driving meaningful change in patient care.
2Morrow Awarded DiMe Seal, Recognized for Excellence in Digital Behavior Change
2Morrow has been named a recipient of the DiMe Seal, a new standard of excellence developed by the Digital Medicine Society (DiMe) in collaboration with Elevance Health. The Seal recognizes digital health software products that meet rigorous standards for clinical strength, usability, privacy, and equity.
[Kirkland, WA - 6/3/2025] – 2Morrow has been named a recipient of the DiMe Seal, a new standard of excellence developed by the Digital Medicine Society (DiMe) in collaboration with Elevance Health. The Seal recognizes digital health software products that meet rigorous standards for clinical strength, usability, privacy, and equity.
With over 337,000 digital health apps available globally, the need for clarity and quality assurance has never been greater. The DiMe Seal was created to provide healthcare leaders with a trusted signal, identifying solutions that are not only innovative, but also backed by meaningful evidence and ready for real-world impact.
“The DiMe Seal is helping redefine how digital health earns trust,” said Jo Masterson, CEO of 2Morrow. “We’re proud to be part of this movement toward greater transparency and rigor. At 2Morrow, we believe that behavior change tools should be grounded in science, accessible to all, and built to scale. This recognition affirms that approach and challenges all of us to keep raising the bar.”
Elevating Evidence-Based Digital Care
2Morrow’s Breathe Bundle - which includes programs for tobacco cessation, stress, weight, and personal goal setting - is the only multi-program solution of its kind recognized in the inaugural DiMe Seal cohort. Designed to support behavior change at scale, the programs are grounded in evidence-based approaches and principles drawn from Acceptance and Commitment Therapy (ACT).
As part of the evaluation process, which included independent review and clinical input from Elevance Health, one of the nation’s largest payers, 2Morrow received a “Strong” recommendation for its clinical evidence. The assessment highlighted randomized trial results, a transparent evidence base, and strong usability across a broad range of populations.
Building a More Trusted Future in Digital Health
2Morrow is proud to be among the first companies to earn this designation and to stand alongside a diverse group of innovators working to define quality in digital health. According to the IQVIA Digital Health Trends 2024 report, only a small fraction of digital health solutions offer published evidence of clinical impact, making initiatives like the DiMe Seal increasingly vital to helping healthcare leaders make confident, informed decisions.
"The influx of innovative digital health software products in our healthcare system can transform how we deliver care, but healthcare leaders need a clear, reliable way to identify which solutions are ready to deliver impact," said Doug Mirsky, Vice President, DiMe Seal. "The DiMe Seal offers that clarity, and we're proud to help elevate organizations like 2Morrow that are building products that exemplify the evidence-backed, scalable innovation the healthcare system needs."
The DiMe Seal reflects a broader shift across the healthcare ecosystem: a demand for solutions that don’t just promise change, but can prove it. For organizations seeking digital programs that are practical, proven, and ready to implement, the Seal provides a new level of confidence.
To learn more about the DiMe Seal, visit:
https://dimesociety.org/dime-seal/
About 2Morrow: 2Morrow is a leading provider of evidence-based digital behavioral health and wellness solutions, including tobacco cessation. Our efforts in assisting people to quit smoking have consistently yielded positive outcomes, supported by a Phase III randomized controlled trial involving 2,400 participants and more than 12 peer-reviewed publications. Trusted by some of the nation's largest employers, states, and health plans, we've empowered over a million individuals on their journey to improved health, showcasing our dedication to expanding access to care. At 2Morrow, we're committed to using innovative technology and research to drive impactful change and expand access to care. For more information, please visit www.2morrowinc.com
Media Contact:
Deanna Waters
VP, Participant Success, 2Morrow
dwaters@2morrowinc.com
NIH SBIR - Center For Scientific Review Special Emphasis Panel in DC on July 6-7
Visit Clinical Care and Health Interventions at https://public.csr.nih.gov/StudySections/DABP/CCHI/CCHI10
Digital Health Today: DTX Podcast Ep55: Enabling Behavior Change Through Acceptance, Awareness and Mindfulness
In this episode, we hear from Jo Masterson, CEO and Co-Founder of 2Morrow and cover: The founding philosophy of 2Morrow and co-founding a company with your partner; The funding journey; The NIH grant for 2Morrow’s program for pain; Using a DTx to cope with pain that will not be effected by behaviour change; Consumer experience using different 2Morrow programs; Core principles of acceptance, awareness and mindfulness, and; Evidence generation and approach to market.
In this episode, we hear from Jo Masterson, CEO and Co-Founder of 2Morrow and cover: The founding philosophy of 2Morrow and co-founding a company with your partner; The funding journey; The NIH grant for 2Morrow’s program for pain; Using a DTx to cope with pain that will not be effected by behaviour change; Consumer experience using different 2Morrow programs; Core principles of acceptance, awareness and mindfulness, and; Evidence generation and approach to market.
425 Business: 2Morrow Inc. Knows How to Help You Kick Your Bad Habits
“More than 50 percent of Americans will set at least one resolution for the new year. Most, though, will be abandoned after an average of two weeks. That hopeful act of goal-setting is something 2Morrow is looking to help its users see to fruition.”
“More than 50 percent of Americans will set at least one resolution for the new year. Most, though, will be abandoned after an average of two weeks. That hopeful act of goal-setting is something 2Morrow is looking to help its users see to fruition.”
Developing Digital Therapeutics for Chronic Pain in Primary Care: A Qualitative Human-Centered Design Study of Providers’ Motivations and Challenges
This study, conducted by University of Washington in collaboration with 2Morrow, examined primary care providers’ motivations for chronic pain management, including their strategies and challenges, to inform the future development of chronic pain-related digital therapeutics tailored to primary care settings.
This study, conducted by University of Washington in collaboration with 2Morrow, examined primary care providers’ motivations for chronic pain management, including their strategies and challenges, to inform the future development of chronic pain-related digital therapeutics tailored to primary care settings.
2Morrow is Awarded $1.9 Million NIH Grant to Develop a Digital Therapeutic for Patients with Chronic Pain
2Morrow, an industry leader in providing evidence-based, digital health solutions focused on behavioral interventions for chronic conditions, has been awarded a $1.9 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant.
2Morrow, an industry leader in providing evidence-based, digital health solutions focused on behavioral interventions for chronic conditions, has been awarded a $1.9 million National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant. Funded by NIH’s Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, the grant will support the research and development of a new digital therapeutic for patients with chronic pain to be used in primary care settings.
In the U.S. alone, over 50 million individuals suffer from chronic pain, many of them dealing with the reality that they will be living with pain for the long term. New pain treatment guidelines from the CDC call for non-pharmacological and non-opioid treatments, including recommendation for behavioral intervention. However, treatment options have not kept up with patient and provider needs. 2Morrow aims to address this critical gap in care by developing a behavioral digital therapeutic for chronic pain that is effective, easy to prescribe and use, and results in improved quality of life and provider satisfaction for patients.
“When I started my career in nursing, I saw that medical care seldom incorporated behavioral support. Even with the move to more integrated care, most patients are not receiving mental, emotional, and behavioral support for living with challenging conditions,” said Principal Investigator Jo Masterson, co-founder and CEO of 2Morrow. “This grant expands on 2Morrow’s previous work by funding critical R&D using digital therapeutics to increase access to behavioral health for those living with pain.”
Research partners at the University of Washington in Seattle have conducted two studies during Phase I of the grant project and are preparing for an upcoming clinical trial. “Patients suffering from chronic pain need better access to scientifically tested behavioral treatments that help them improve how they function and ultimately, improve the quality of their lives,” said Dr. Kari Stephens, Research Section Head in Family Medicine, University of Washington School of Medicine. “Testing digital therapeutics will help us learn whether mobile app-based technologies can offer an effective way to deliver this kind of care.”
This award is funded by the National Center for Complementary and Integrative Health (NCCIH) and National Institute of Neurological Disorders and Stroke (NINDS) of the NIH under award number R44AT011593.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Smoking Is Still the #1 Preventable Cause of Death and Disease—Here’s What Employers Can Do About It
One of a company’s most important assets is its employees. Companies invest a significant amount of time and money (in excess of $4,400) to recruit, train, develop, and retain each team member.
One of a company’s most important assets is its employees. Companies invest a significant amount of time and money (in excess of $4,400) to recruit, train, develop, and retain each team member. This is on top of wages, benefits, and other perks. How can employers protect this investment? One way is by addressing the single preventable cause of death and disability—smoking and tobacco use.
2Morrow’s Chief Science Officer, Dr. Sue Zbikowski, discusses this as a guest blogger for Castlight.
Interact For Health: Q&A with Sue Zbikowski, Ph.D., Chief Science Officer for 2Morrow
Interact For Health interviews Sue Zbikowski to learn more about her extensive background in smoking cessation research, how cessation programs have changed over the years, and how 2Morrow has played an immense role in the evolution of the programs.
Interact For Health interviews Sue Zbikowski to learn more about her extensive background in smoking cessation research, how cessation programs have changed over the years, and how 2Morrow has played an immense role in the evolution of the programs.
Together with Virgin Pulse: Building Better Mental Health Benefits
“Improving your mental health and wellbeing benefits doesn’t have to be a huge undertaking. We’re here to help make it easier. Leverage the content in this eBook to learn more about each partner (including 2Morrow) and how they uniquely support mental health and wellbeing needs together with Virgin Pulse.”
“Improving your mental health and wellbeing benefits doesn’t have to be a huge undertaking. We’re here to help make it easier. Leverage the content in this eBook to learn more about each partner (including 2Morrow) and how they uniquely support mental health and wellbeing needs together with Virgin Pulse.”
KXLY: SRHD Introduces 2Morrow Health, a New App That Helps Those Wanting to Stop Vaping or Smoking
The Spokane Regional Health District introduces the 2Morrow Smoking & Tobacco and Vaping for Teens and Young Adults to its community.
In this episode, we hear from Jo Masterson, CEO and Co-Founder of 2Morrow and cover: The founding philosophy of 2Morrow and co-founding a company with your partner; The funding journey; The NIH grant for 2Morrow’s program for pain; Using a DTx to cope with pain that will not be effected by behaviour change; Consumer experience using different 2Morrow programs; Core principles of acceptance, awareness and mindfulness, and; Evidence generation and approach to market.
CNN: 6 Steps You Can Take to Quit Smoking and Live a Healthier Life
“Cigarette smoking is very addictive and can have long-term, adverse health effects. But there is hope for those who want to quit thanks to innovative apps, help lines and proven coping strategies.” This article specifically talks about how the iCanQuit app can help.
“Cigarette smoking is very addictive and can have long-term, adverse health effects. But there is hope for those who want to quit thanks to innovative apps, help lines and proven coping strategies.”
This article specifically talks about how the iCanQuit app can help.
There’s a National Mental Health Crisis: Here’s How Castlight Can Help
The 2022 Workforce Health Index shows that, in 2021, one in four individuals self-reported feeling down, depressed, or hopeless several days over a two-week span, a 21% increase from 2019.
“The 2022 Workforce Health Index shows that, in 2021, one in four individuals self-reported feeling down, depressed, or hopeless several days over a two-week span, a 21% increase from 2019.
When we identify a member who needs behavioral health support of some kind, we steer them toward high-value and clinically-validated solutions (ideally covered by their employer), such as a provider or a digital behavioral health solution—like one of our mental health-focused Ecosystem partners.”
GeekWire: A List of Mental Health Startups in the Pacific Northwest, as Pandemic Fuels Growth for Sector
The pandemic has been hard on people’s mental health. And it’s changed almost everyone’s approach to everyday life, as Zoom, Teams, Slack and other digital products mediate ever more human interactions.
“The pandemic has been hard on people’s mental health. And it’s changed almost everyone’s approach to everyday life, as Zoom, Teams, Slack and other digital products mediate ever more human interactions.
Health companies saw the need and opportunity. In the last couple years, a host of new apps, telehealth services and other digital solutions have sprung up to support mental health.”
Digital Health Science News: A New Study Finds That a Smoking Cessation App Can Reach a Diverse Group of Users
To better understand which populations will use digital tobacco cessation programs, 2Morrow, in collaboration with Washington State Department of Health (DOH), conducted an observational study of 1280 adult Washington State residents who registered for and activated the 2Morrow Health cessation app between 2018 and 2020.
To better understand which populations will use digital tobacco cessation programs, 2Morrow, in collaboration with Washington State Department of Health (DOH), conducted an observational study of 1280 adult Washington State residents who registered for and activated the 2Morrow Health cessation app between 2018 and 2020. The study, published in the open access journal JMIR Public Health and Surveillance, shows that a digital cessation app to quit smoking can draw a diverse audience including at-risk and underrepresented groups.
The full research article can be found here.
DeviceConnect: Capturing The Emerging Opportunities in Digital Health - Speaking Panel - 10/14/21 at 4PM PST
Emerging technologies in digital health are changing the landscape of healthcare forever. From diagnostics to treatment and therapeutics, to health maintenance and beyond, innovators in this space aren’t promising small changes — they’re promising a better healthcare experience through more engaged patient involvement, better access to providers, and improved outcomes.
Emerging technologies in digital health are changing the landscape of healthcare forever. From diagnostics to treatment and therapeutics, to health maintenance and beyond, innovators in this space aren’t promising small changes — they’re promising a better healthcare experience through more engaged patient involvement, better access to providers, and improved outcomes. Join Jo Masterson and other distinguished experts on 10/14/21 at 4pm PST for this exciting session where we’ll hear about emerging innovations and what opportunities lie ahead.
The Tech Tribune: Profile of a Founder
Learn about 2Morrow’s story of origin, hurdles that have been encountered, what the future holds, and advice for aspiring entrepreneurs in an exclusive Tech Tribune Q&A with Jo Masterson, co-founder and CEO. 2Morrow was honored by The Tech Tribune in 2019 as a ‘Best Tech Startup in Kirkland’.
Learn about 2Morrow’s story of origin, hurdles that have been encountered, what the future holds, and advice for aspiring entrepreneurs in an exclusive Tech Tribune Q&A with Jo Masterson, co-founder and CEO. 2Morrow was honored by The Tech Tribune in 2019 as a ‘Best Tech Startup in Kirkland’.
GeekWire: Behavioral Science Startup 2Morrow Raises $1.5M to Grow Digital Therapeutic Platform
2Morrow, a Seattle-area startup that develops digital coaching software to help people reach health goals, has raised $1.5 million. Total funding to date is $2.9 million.
2Morrow, a Seattle-area startup that develops digital coaching software to help people reach health goals, has raised $1.5 million. Total funding to date is $2.9 million.
2Morrow said 2020 was its best year yet as the pandemic spurred demand for digital health services that can be delivered remotely. The 11-person startup rolled out a new program to help people deal with the mental and emotional toll of grief, loss, and change.